로고
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
Search
Search
Company
People
History
Collaboration
Location
Science
Pipeline
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Animals
Growing Industry
Farm Animal
Companion Animal
IR
News
Events
Financial Information
FAQS
Jobs
Jobs
CLOSE

History 

History of Plumbline

2017.

• Awarded a Grant funded by Ministry of Small and Medium Eneterprizes and Startups-“Evaluation of Immunogenicity of FMD Trivalent DNA Vaccine in SPF Mini Pig”
• IP R&D order and agreement to strengthen the technology for the anti-cancer immunotherapy DNA vaccine.
• New lab facility at The Catholic University of Korea
• 2017 awarded government sponsorial project for PLS-5000(solid cancer treatment for dogs)
• Submission for approval to begin clinical trial made to USDA in Feb. 2017(for B-cell Lymphoma indication)

2016.

• PLS-D1000 Efficacy Test in Korea
• PLS-D5000 Exploratory safety study in 7 healthy dogs conducted in 2016 after receiving approval form USDA to ship product
• LifeTide® SW5 Approval application in Korea

2015.

• Listed in KONEX (2015.7.28)

2014.

• Plumbline Life Sciences, USA established
(100% Subsidiary)
• MOU about Manufacturing Investment with Gyeonggi-do government
• 100% Acquisition of VGX Animal Health Assets

2012.

• LifeTide® SW5 Approval in New Zealand

2008.

• LifeTide® SW5 Approval in Australia

2007.

• Renamed as ‘VGX Animal Health’ after acquired by VGX Pharmaceuticals

2001.

• Renamed as ‘ADVISYS’

1997.

• Established ‘Applied Veterinary Systems’ in Texas